Clinical Pharmacology Considerations for Peptide Drug Products
thought leadership
SEPTEMBER 20, 2023
The FDA has recently issued this draft guidance to address clinical pharmacology considerations for peptide drug products. These products fall somewhere between drugs and biologics and do not have the usually well-defined characteristics of either category. A peptide is any polymer with 40 or fewer amino acids.
Let's personalize your content